The Diagnostic Research Industry is playing an integral part in the medical evaluation and treatment of patients. This industry is vital to the healthcare market
Interpace Biosciences, Inc [NASDAQ: IDXG] announced today that the Board of Directors Audit Committee found the complaints regarding some billing and employment issues that have
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.